Teveten HCT and Breastfeeding
It may not be safe for women to take Teveten HCT (eprosartan/HCTZ) while breastfeeding. One of the components in this product does pass through breast milk in small amounts, but does not appear to be harmful to a breastfed infant. However, no research has been done on the other component in Teveten HCT, so it is not known what potential problems this drug might cause.
Can Breastfeeding Women Take Teveten HCT?Teveten® HCT (eprosartan/HCTZ) is a prescription medication approved to treat hypertension (high blood pressure). It contains two blood pressure medications. At least one of these medications is known to pass through breast milk. Therefore, if you are breastfeeding a child, talk with your healthcare provider before taking Teveten HCT.
More Information on Teveten HCT and BreastfeedingHydrochlorothiazide, one of the components of Teveten HCT, passes through breast milk in very small amounts. Many experts consider it safe for use during breastfeeding if doses are lower than 50 mg a day. Although higher doses may not be harmful to a nursing child, they may reduce breast milk production.
No studies have been done to see if eprosartan, the other component in Teveten HCT, passes through breast milk. Because of the lack of research, it is unknown if this medication is safe for use in women who are breastfeeding.
Talking With Your Healthcare ProviderYou should discuss breastfeeding and Teveten HCT use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.